Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Ocular Posterior Segment Involvement in Patients with Antiphospholipid Syndrome and Systemic Lupus Erythematosus.

Kucukkomurcu E, Unal AU, Esen F, Ozen G, Direskeneli H, Kazokoglu H.

Ocul Immunol Inflamm. 2018 Dec 17:1-6. doi: 10.1080/09273948.2018.1552759. [Epub ahead of print]

PMID:
30556792
2.

Triggering agents and microbiome as environmental factors on Behçet's syndrome.

Mumcu G, Direskeneli H.

Intern Emerg Med. 2018 Dec 6. doi: 10.1007/s11739-018-2000-1. [Epub ahead of print] Review.

PMID:
30523495
3.

Does illness perception associate with disease symptoms in Behçet's disease?

Mumcu G, Yağar F, Alibaz-Öner F, İnanç N, Direskeneli H, Ergun T.

Intern Emerg Med. 2018 Nov 30. doi: 10.1007/s11739-018-1983-y. [Epub ahead of print]

PMID:
30506212
4.

The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors.

İris M, Özçıkmak E, Aksoy A, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H, Mumcu G.

Eur J Rheumatol. 2018 Dec;5(4):240-243. doi: 10.5152/eurjrheum.2018.18094. Epub 2018 Oct 12.

5.

Exon 2: Is it the good police in familial mediterranean fever?

Bilge ŞY, Solmaz D, Şenel S, Emmungil H, Kılıç L, Öner SY, Yıldız F, Yılmaz S, Bozkırlı DE, Tufan MA, Yılmaz S, Yazısız V, Pehlivan Y, Beş C, Çetin GY, Erten Ş, Gönüllü E, Şahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kısacık B, Sayarlıoğlu M, Çınar M, Kaşifoğlu T, Sarı İ.

Eur J Rheumatol. 2018 Oct 12. doi: 10.5152/eurjrheum.2018.18115. [Epub ahead of print]

PMID:
30489254
6.

Oral health is a mediator for disease severity in patients with Behçet's disease: A multiple mediation analysis study.

Yay M, Çelik Z, Aksoy A, Alibaz-Öner F, Inanç N, Ergun T, Direskeneli H, Mumcu G.

J Oral Rehabil. 2018 Nov 22. doi: 10.1111/joor.12750. [Epub ahead of print]

PMID:
30466164
7.

Pulmonary hypertension in Takayasu's arteritis: Should be monitored closely.

Direskeneli H.

Int J Cardiol. 2019 Feb 1;276:238-239. doi: 10.1016/j.ijcard.2018.10.074. Epub 2018 Oct 28. No abstract available.

PMID:
30391066
8.

Factors Affecting Relapse and Remission in Behçet's Uveitis Treated with Interferon Alpha2a.

Celiker H, Kazokoglu H, Direskeneli H.

J Ocul Pharmacol Ther. 2018 Oct 25. doi: 10.1089/jop.2018.0083. [Epub ahead of print]

PMID:
30359208
9.

Prevalence of inflammatory back pain and radiologic sacroiliitis is increased in patients with primary Sjögren's syndrome.

Eren R, Can M, Alibaz-Öner F, Yilmaz-Oner S, Yilmazer B, Cefle A, Direskeneli H, Atagündüz P.

Pan Afr Med J. 2018 Jun 5;30:98. doi: 10.11604/pamj.2018.30.98.15588. eCollection 2018.

10.

Conventional immunosuppressive therapy in severe Behcet's Uveitis: the switch rate to the biological agents.

Celiker H, Kazokoglu H, Direskeneli H.

BMC Ophthalmol. 2018 Oct 5;18(1):261. doi: 10.1186/s12886-018-0929-5.

11.

Analysis of the genetic component of systemic sclerosis in Iranian and Turkish populations through a genome-wide association study.

González-Serna D, López-Isac E, Yilmaz N, Gharibdoost F, Jamshidi A, Kavosi H, Poursani S, Farsad F, Direskeneli H, Saruhan-Direskeneli G, Vargas S, Sawalha AH, Brown MA, Yavuz S, Mahmoudi M, Martin J.

Rheumatology (Oxford). 2018 Sep 21. doi: 10.1093/rheumatology/key281. [Epub ahead of print]

PMID:
30247649
12.

Ocular findings and blood flow in patients with Takayasu arteritis: a cross-sectional study.

Esen F, Ergelen R, Alibaz-Öner F, Çelik G, Direskeneli H, Kazokoğlu H.

Br J Ophthalmol. 2018 Aug 27. pii: 10.1136/bjophthalmol-2018-312580. doi: 10.1136/bjophthalmol-2018-312580. [Epub ahead of print]

PMID:
30150277
13.

Takayasu arteritis: an update

Keser G, Aksu K, Direskeneli H.

Turk J Med Sci. 2018 Aug 16;48(4):681-697. doi: 10.3906/sag-1804-136. Review.

PMID:
30114347
14.

Certolizumab pegol in the treatment of Takayasu arteritis.

Novikov PI, Smitienko IO, Sokolova MV, Alibaz-Oner F, Kaymaz-Tahra S, Direskeneli H, Moiseev SV.

Rheumatology (Oxford). 2018 Dec 1;57(12):2101-2105. doi: 10.1093/rheumatology/key197.

PMID:
30010945
15.

Management of vascular Behçet's disease.

Alibaz-Oner F, Direskeneli H.

Int J Rheum Dis. 2018 Apr 17. doi: 10.1111/1756-185X.13298. [Epub ahead of print] No abstract available.

PMID:
29665281
16.

Impaired cardiac and vascular motion in patients with Takayasu's arteritis: A velocity vector imaging-based study.

Yurdakul S, Alibaz-Öner F, Direskeneli H, Aytekin S.

Eur J Rheumatol. 2018 Mar;5(1):16-21. doi: 10.5152/eurjrheum.2017.16108. Epub 2017 Oct 25.

17.

Management of Behçet's disease.

Alibaz-Oner F, Sawalha AH, Direskeneli H.

Curr Opin Rheumatol. 2018 May;30(3):238-242. doi: 10.1097/BOR.0000000000000497.

PMID:
29432223
18.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B, Diamantopoulos AP, Direskeneli H, Iagnocco A, Klink T, Neill L, Ponte C, Salvarani C, Slart RHJA, Whitlock M, Schmidt WA.

Ann Rheum Dis. 2018 May;77(5):636-643. doi: 10.1136/annrheumdis-2017-212649. Epub 2018 Jan 22.

19.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2018 Mar 1;27(5):941-942. doi: 10.1093/hmg/ddy015. No abstract available.

PMID:
29346566
20.

Comparison of early versus late onset familial Mediterranean fever.

Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Sayarlioglu M, Cınar M, Kasifoglu T.

Int J Rheum Dis. 2018 Apr;21(4):880-884. doi: 10.1111/1756-185X.13259. Epub 2018 Jan 5.

PMID:
29314707
21.

Increased stiffness of median nerve in systemic sclerosis.

Yagci I, Kenis-Coskun O, Ozsoy T, Ozen G, Direskeneli H.

BMC Musculoskelet Disord. 2017 Nov 7;18(1):434. doi: 10.1186/s12891-017-1793-9.

22.

Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.

Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1090-1094. doi: 10.1002/acr.23446. Epub 2018 Apr 24.

PMID:
28992387
23.

Health-related outcomes of importance to patients with Takayasu's arteritis.

Sreih AG, Alibaz-Oner F, Easley E, Davis T, Mumcu G, Milman N, Robson J, Direskeneli H, Merkel PA, Cronholm P.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):51-57. Epub 2017 Sep 18.

24.

Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.

Keser G, Aksu K, Direskeneli H.

Rheumatology (Oxford). 2018 May 1;57(5):784-790. doi: 10.1093/rheumatology/kex333. Review.

PMID:
28968895
25.

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.

Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ.

Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.

PMID:
28968808
26.

An update on the role of epigenetics in systemic vasculitis.

Coit P, Direskeneli H, Sawalha AH.

Curr Opin Rheumatol. 2018 Jan;30(1):4-15. doi: 10.1097/BOR.0000000000000451. Review.

27.

Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?

Kiykim A, Mumcu G, Ogulur I, Karakoc-Aydiner E, Direskeneli H, Baris S, Cagan H, Ozen A.

Int Arch Allergy Immunol. 2017;174(1):52-56. doi: 10.1159/000480082. Epub 2017 Sep 27.

PMID:
28950285
28.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

29.

Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis.

J Rheumatol. 2017 Dec;44(12):1928-1932. doi: 10.3899/jrheum.161269. Epub 2017 Sep 1.

PMID:
28864648
30.

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Sreih AG, Alibaz-Oner F, Kermani TA, Aydin SZ, Cronholm PF, Davis T, Easley E, Gul A, Mahr A, McAlear CA, Milman N, Robson JC, Tomasson G, Direskeneli H, Merkel PA.

J Rheumatol. 2017 Dec;44(12):1933-1937. doi: 10.3899/jrheum.161467. Epub 2017 Sep 1.

31.

Takayasu's arteritis: A new era is approaching.

Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e177. doi: 10.1016/j.lpm.2017.08.006. No abstract available.

PMID:
28843640
32.

Outcomes of Patients with Behçet's Syndrome after Pulmonary Endarterectomy.

Yıldızeli ŞO, Yanartaş M, Taş S, Direskeneli H, Mutlu B, Ceyhan B, Yıldızeli B.

Thorac Cardiovasc Surg. 2018 Mar;66(2):187-192. doi: 10.1055/s-0037-1604411. Epub 2017 Aug 15.

PMID:
28810271
33.

Patient-reported outcomes in Takayasu's arteritis.

Alibaz-Oner F, Sreih AG, Merkel PA, Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e225-e227. doi: 10.1016/j.lpm.2017.03.023. Epub 2017 Jul 26.

PMID:
28756078
34.

Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.

Celiker H, Kazokoglu H, Direskeneli H.

Ocul Immunol Inflamm. 2017 Jul 12:1-8. doi: 10.1080/09273948.2017.1332768. [Epub ahead of print]

PMID:
28700247
35.

Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

Mumcu G, Alibaz-Öner F, Öner SY, Özen G, Atagündüz P, İnanç N, Köksal L, Ergun T, Direskeneli H.

Eur J Rheumatol. 2017 Jun;4(2):109-112. doi: 10.5152/eurjrheum.2017.160094. Epub 2017 Jun 1.

36.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2017 Jul 1;26(13):2577-2588. doi: 10.1093/hmg/ddx151. Erratum in: Hum Mol Genet. 2018 Mar 1;27(5):941-942.

PMID:
28449029
37.

Reply to: Behçet's disease: an MHC-I-opathy?

McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):6. Epub 2017 Apr 14. No abstract available.

38.

Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.

Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.

Immunol Invest. 2017 Jul;46(5):518-525. doi: 10.1080/08820139.2017.1306865. Epub 2017 Apr 17.

PMID:
28414558
39.

Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.

Ozen G, Deniz R, Eren F, Erzik C, Unal AU, Yavuz S, Aydin SZ, Inanc N, Direskeneli H, Atagunduz P.

Open Rheumatol J. 2017 Jan 16;11:1-9. doi: 10.2174/1874312901711010001. eCollection 2017.

40.

Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium.

Sci Rep. 2017 Apr 5;7:46012. doi: 10.1038/srep46012. No abstract available.

41.

Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis. De Luca G. et al.

Alibaz-Oner F, Direskeneli H.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):222. Epub 2017 Mar 31. No abstract available.

PMID:
28375839
42.

Clinical assessment in Takayasu's arteritis: major challenges and controversies.

Direskeneli H.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):189-193. Epub 2017 Mar 27. Review.

PMID:
28375833
43.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA.

J Rheumatol. 2017 Nov;44(11):1750-1753. doi: 10.3899/jrheum.161352. Epub 2017 Apr 1.

PMID:
28365574
44.

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium.

Sci Rep. 2017 Mar 9;7:43953. doi: 10.1038/srep43953. Erratum in: Sci Rep. 2017 Apr 05;7:46012.

45.

Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Özdemir FT, Demiralp EE, Aydın SZ, Atagündüz P, Ergun T, Direskeneli H.

Eur J Rheumatol. 2016 Dec;3(4):146-152. doi: 10.5152/eurjrheum.2016.15099. Epub 2016 Dec 1.

46.

Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.

Omma A, Erer B, Karadag O, Yilmaz N, Alibaz-Oner F, Yildiz F, Kalfa M, Kimyon G, Kiraz S, Direskeneli H, Erken E, Aksu K, Onat AM, Gül A, Ocal L, Inanc M, Kamali S.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):77-82. Epub 2016 Nov 10.

PMID:
27908308
47.

Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis.

Salman A, Sonmez Y, Sahin H, Unal AU, Direskeneli H, Cinel L, Ergun T.

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12443. Epub 2016 Nov 12. No abstract available.

PMID:
27862745
48.

Severe neuro-Behcet's disease treated with a combination of immunosuppressives and a TNF-inhibitor.

Korkmaz FN, Ozen G, Ünal AU, Kahraman Koytak P, Tuncer N, Direskeneli H.

Acta Reumatol Port. 2016 Oct-Dec;41(4):367-371.

49.

Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.

Hamuryudan V, Direskeneli H, Ertenli I, Inanc M, Karaaslan Y, Oksel F, Ozbek S, Pay S, Terzioglu E, Balkan Tezer D, Hacibedel B, Akkoc N.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1033-1037. Epub 2016 Sep 18.

PMID:
27749224
50.

Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A + HBV study).

Kalyoncu U, Emmungil H, Onat AM, Yılmaz S, Kaşifoglu T, Akar S, İnanç N, Yıldız F, Küçükşahin O, Karadağ Ö, Mercan R, Bes C, Yazısız V, Yılmazer B, Özmen M, Erten Ş, Şenel S, Yazıcı A, Taşçılar K, Kalfa M, Kiraz S, Kısacık B, Pehlivan Y, Kılıç L, Şimşek İ, Çefle A, Akkoç N, Direskeneli H, Erken E, Turgay M, Öztürk MA, Soy M, Aksu K, Dinç A, Ertenli İ.

Eur J Rheumatol. 2015 Dec;2(4):149-154. Epub 2015 Dec 1.

Supplemental Content

Loading ...
Support Center